TXG as of Nov 1 · 08:19 ET
TXGNasdaqLaboratory Analytical Instruments
10x Genomics, Inc. · Brief
Next report
4 days
Nov 5 · after closeconfirmedQ3 FY26
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±15.8%
- avg realized
- ±6.0%
Feb 12 '25±13.0%▼−0.50%×0.04
May 8 '25±16.3%▲+1.62%×0.10
Aug 7 '25±12.3%▼−3.98%×0.32
Q3 FY25±25.4%▲+17.31%×0.68
Jan 12 '26±11.3%▼−3.23%×0.29
Feb 12 '26±19.1%▲+3.48%×0.18
Q1 FY26±14.4%▼−3.66%×0.25
Q2 FY26±14.8%▲+14.10%×0.96
quarterimplied−30%0+30%realized×
Q2 FY26±14.8%▲+14.10%×0.96
Q1 FY26±14.4%▼−3.66%×0.25
Feb '26±19.1%▲+3.48%×0.18
Jan '26±11.3%▼−3.23%×0.29
Q3 FY25±25.4%▲+17.31%×0.68
Aug '25±12.3%▼−3.98%×0.32
2 older reports
May '25±16.3%▲+1.62%×0.10
Feb '25±13.0%▼−0.50%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · confirmedBull2 of 4
Bear2 of 3
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
TXG report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.